OptimizeRx Corporation
OPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -10.7% | 33.1% | -32.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.2% | 63.8% | 60.9% | 68.1% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 12.1% | 15% | -4.1% | 15.1% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 3% | 5.2% | -10% | -0.2% |
| EPS Diluted | 0.04 | 0.081 | -0.12 | 0 |
| % Growth | -50.4% | 167.2% | – | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |